Ergoteles’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-50,500
Closed -$169K 1048
2023
Q1
$169K Sell
50,500
-5,531
-10% -$18.5K 0.01% 1040
2022
Q4
$270K Buy
+56,031
New +$270K 0.01% 950
2021
Q2
Sell
-50,362
Closed -$3.11M 1484
2021
Q1
$3.11M Buy
+50,362
New +$3.11M 0.1% 226